ZAPOFY
Live / Applied — Third extension granted (statement of use) (as of 03 Mar 2026)
What this means for you
Not registered yet, but its 05 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98434521
- Mark type
- Stylized text
- Filed
- 05 Mar 2024
- Published for opposition
- 29 Oct 2024
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
Owner
- Conjupro Biotherapeutics Inc., Princeton, NJ, US
- Conjupro Biotherapeutics Inc., Princeton, NJ, US
Prosecution history
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 3 GRANTED
- 03 Mar 2026 — SOU EXTENSION 3 FILED
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — SOU EXTENSION 2 GRANTED
- 03 Sept 2025 — SOU EXTENSION 2 FILED
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2025 — SOU EXTENSION 1 GRANTED
- 04 Mar 2025 — SOU EXTENSION 1 FILED
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2024 — PUBLISHED FOR OPPOSITION